LogicBio Therapeutics, Inc.

LEXINGTON, MA How do I update this listing?

Logicbio Therapeutics is based out of Lexington. LogicBio Therapeutics, Inc. operates as a biotechnology company. The Company develops therapeutic gene therapy vectors for the treatment of genetic and infectious diseases. LogicBio Therapeutics serves patients in the State of Massachusetts. The firm last filed a Form D notice of exempt offering of securities on 2017-07-05. The notice included securities offered of Equity

Create Alert

Contact Info

logicbio therapeutics, inc.
65 HAYDEN AVE
LEXINGTON MA    02421

Business Phone: 617-245-0399
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2017-07-05 D BIOTECHNOLOGY Equity 44,894,260 29,181,271 15,712,989
2016-01-21 D OTHER HEALTH CARE Equity 5,399,900 3,999,911 1,399,989
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ADI BARZEL subscription required
    EXECUTIVE OFFICER DIRECTOR
DANIEL O'CONNELL subscription required
    DIRECTOR
EREZ CHIMOVITS subscription required
    DIRECTOR
FREDERIC CHEREAU subscription required
    EXECUTIVE OFFICER DIRECTOR
LEON CHEN subscription required
    DIRECTOR
LESZEK LISOWSKI subscription required
    EXECUTIVE OFFICER DIRECTOR
MARC RUBENSTEIN subscription required
    EXECUTIVE OFFICER
MARK A. KAY subscription required
    DIRECTOR
SOFIA IOANNIDOU subscription required
    DIRECTOR
TOMER KARIV subscription required
    DIRECTOR

Elevate your investments